| LP250693-1 | Data items collected at inpatient facility admission or agency discharge only - transfer | COMPONENT | 1 |
| LP250694-9 | Crimean-Congo hemorrhagic fever virus Ab | COMPONENT | |
| LP250695-6 | Crimean-Congo hemorrhagic fever virus IgM | COMPONENT | 1 |
| LP250696-4 | Crimean-Congo hemorrhagic fever virus IgG | COMPONENT | 1 |
| LP250697-2 | Ebola and Marburg virus | COMPONENT | |
| LP250698-0 | Ebola and Marburg virus RNA | COMPONENT | |
| LP250699-8 | Ebola and Marburg virus RNA Panel | COMPONENT | 1 |
| LP250701-2 | European tick borne encephalitis virus RNA | COMPONENT | 3 |
| LP250702-0 | Erysipelothrix sp strain 2 DNA | COMPONENT | 1 |
| LP250703-8 | Erysipelothrix sp strain 2 | COMPONENT | |
| LP250706-1 | Outcome and assessment information set (OASIS) form - version C2 - Discharged from agency | COMPONENT | 1 |
| LP250707-9 | Sensory status - discharge from agency | COMPONENT | 1 |
| LP250708-7 | Influenza virus types A and B panel | COMPONENT | 5 |
| LP250834-1 | Neuro and emotional and behavioral status - SOC or ROC | COMPONENT | 1 |
| LP250835-8 | Erysipelothrix tonsillarum DNA | COMPONENT | 1 |
| LP250836-6 | Erysipelothrix tonsillarum | COMPONENT | |
| LP250843-2 | Vedolizumab | COMPONENT | 1 |
| LP250846-5 | Vedolizumab Ab | COMPONENT | 1 |
| LP250847-3 | Certolizumab | COMPONENT | 1 |
| LP250850-7 | Certolizumab Ab | COMPONENT | 2 |
| LP250851-5 | Ustekinumab | COMPONENT | 1 |
| LP250854-9 | Ustekinumab Ab | COMPONENT | 2 |
| LP250855-6 | Golimumab | COMPONENT | 1 |
| LP250858-0 | Golimumab Ab | COMPONENT | 1 |
| LP250859-8 | Microarray | METHOD | 6 |
| LP250860-6 | Full field digital mammogram | METHOD | 10 |
| LP250893-7 | Chemotherapy infusion start time | COMPONENT | 1 |
| LP250894-5 | Chemotherapy infusion stop time | COMPONENT | 1 |
| LP250895-2 | Retinal nerve fiber layer.clock hour 12 thickness | COMPONENT | 2 |
| LP250896-0 | Retinal nerve fiber layer.clock hour 1 thickness | COMPONENT | 2 |
| LP250897-8 | Retinal nerve fiber layer.clock hour 2 thickness | COMPONENT | 2 |
| LP250898-6 | Retinal nerve fiber layer.clock hour 3 thickness | COMPONENT | 2 |
| LP250899-4 | Retinal nerve fiber layer.clock hour 4 thickness | COMPONENT | 2 |
| LP250900-0 | Retinal nerve fiber layer.clock hour 5 thickness | COMPONENT | 2 |
| LP250901-8 | Retinal nerve fiber layer.clock hour 6 thickness | COMPONENT | 2 |
| LP250902-6 | Retinal nerve fiber layer.clock hour 7 thickness | COMPONENT | 2 |
| LP250903-4 | Retinal nerve fiber layer.clock hour 8 thickness | COMPONENT | 2 |
| LP250904-2 | Retinal nerve fiber layer.clock hour 9 thickness | COMPONENT | 2 |
| LP250905-9 | Retinal nerve fiber layer.clock hour 10 thickness | COMPONENT | 2 |
| LP250906-7 | Retinal nerve fiber layer.clock hour 11 thickness | COMPONENT | 2 |
| LP250907-5 | Minimum Data Set (MDS) - version 3.0 - Resident Assessment and Care Screening (RAI) version 1.14.1 | COMPONENT | 1 |
| LP250908-3 | MDS v3.0 - RAI v1.14.1 - Nursing home comprehensive (NC) item set | COMPONENT | 1 |
| LP250909-1 | MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Identification information | COMPONENT | 1 |
| LP250910-9 | Type of assessment | COMPONENT | 1 |
| LP250911-7 | SNF Part A PPS discharge assessment | COMPONENT | 1 |
| LP250912-5 | Unit certification or licensure designation | COMPONENT | 1 |
| LP250913-3 | Trichomonas vaginalis & Mycoplasma genitalium | COMPONENT | |
| LP250914-1 | Trichomonas vaginalis & Mycoplasma genitalium DNA | COMPONENT | |
| LP250915-8 | Sulfur | COMPONENT | 2 |
| LP250916-6 | Phosphorus | COMPONENT | 2 |